Role
Director of the Molecular and Pharmaco-Epidemiology Unit at the Department of Experimental Oncology of the European Institute of Oncology in Milan (IEO); Tenure Group Leader and member of the Research Council of the same institute
Bio
She graduated in Statistics from the University of Bologna, obtained a Master's in Biometrics from the University of Reading (UK) , and a PhD in Cancer Studies from the University of Birmingham (UK) . Since 2018, she has been Tenure Group Leader and Director of the Molecular and Pharmaco-Epidemiology Unit at the Department of Experimental Oncology at the European Institute of Oncology (IEO) in Milan. She is also an adjunct professor of Medical Statistics at the University of Milan and a lecturer on the PhD in Systems Medicine at SEMM.
Her research integrates epidemiology, biostatistics, and clinical and translational research, with a focus on cancer prevention, risk factors, biomarkers, and precision oncology. A central aspect of her work is the rigorous and critical application of statistical methods, the evaluation of the quality of scientific evidence, and the criteria underlying evidence-based medicine . Recent lines of research include personalized prevention, lifestyle interventions, and the study of low-dose pharmacological strategies, as well as microbiome, metabolomics, radiomics, and artificial intelligence applied to oncology.
She is the author of over 400 scientific publications, has a Scopus H-index of 74 (July 2026), and is included in the Stanford University World's Top 2% Scientists ranking .